dolutegravir 50 mg (equivalent to 52.6 mg dolutegravir sodium) / rilpivirine 25 mg (equivalent to 27.5 mg rilpivirine HCl) Oral Tablet
- RxCUI
- 1989500
- RxNorm name
- dolutegravir 50 mg (equivalent to 52.6 mg dolutegravir sodium) / rilpivirine 25 mg (equivalent to 27.5 mg rilpivirine HCl) Oral Tablet
- Display name
- dolutegravir 50 mg (equivalent to 52.6 mg dolutegravir sodium) / rilpivirine 25 mg (equivalent to 27.5 mg rilpivirine HCl) Oral Tablet
- Full name
- dolutegravir 50 mg (equivalent to 52.6 mg dolutegravir sodium) / rilpivirine 25 mg (equivalent to 27.5 mg rilpivirine HCl) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Juluca | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | ViiV Healthcare Company | 806653d1-bf35-4924-b999-ad5d21821cc1 | 2025-10-29 | Warnings, Adverse reactions | 1989500 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 806653d1-bf35-4924-b999-ad5d21821cc1 | dolutegravir 50 MG / rilpivirine 25 MG Oral Tablet [PSN] · dolutegravir 50 MG / rilpivirine 25 MG Oral Tablet [SCD] · dolutegravir 50 mg (equivalent to 52.6 mg dolutegravir sodium) / rilpivirine 25 mg (equivalent to 27.5 mg rilpivirine HCl) Oral Tablet [SY] | 3 | 15 | These highlights do not include all the information needed to use JULUCA safely and effectively. See full prescribing information for JULUCA. JULUCA (dolutegravir and rilpivirine tablets), for oral use Initial U.S. Approval: 2017 | 20251029 |